Bibliometric Analysis
Journal Bibliometric Report (2021)
The Journal Bibliometric Report is based on all publications in Medline/Pubmed that were cited by Medline/Pubmed publications in 2021.
Details for "Profiles Drug Subst Excip Relat Methodol"
Full Journal Title(s)
- Profiles of drug substances, excipients, and related methodology
Journal Field(s)
Publications and Citation Counts by Year
For each year, the table below lists the number of citable publications [Citable Pubs]; the total number of times citable publications were cited in 2021, including self-citations [Cites From 2021 (All)]; the cumulative percent of the number of times citable publications were cited by publications in 2021, including self-citations [Cites (All) Cumulative %]; the total number of times citable publications were cited in 2021, not including self-citations [Cites From 2021 (No-Self)]; the cumulative percent of the number of times citable publications were cited by publications in 2021, not including self-citations [Cites (No-Self) Cumulative %]; the percentage of citations that were self-citations [% Self Cites]; and the impact factor, which is the number of times citable articles from the previous two years were cited in the given year [Impact Factor]. Citable publications are those whose Medline/Pubmed type is "Journal Article", which in general includes things like original research, meta-analysis, and reviews, but does not include editorials or letters. Self-citations are those where an author cites a previous publication that he or she wrote. Self-citation does NOT mean an article in a journal citing an article in that same journal.
| Year | Citable Pubs | Cites From 2021 (All) | Cites (All) Cumulative % | Cites From 2021 (No-Self) | Cites (No-Self) Cumulative % | % Self Cites | Impact Factor |
|---|---|---|---|---|---|---|---|
| 2026 | 5 | 0 | 0.00 | 0 | 0.00 | 0.00 | - |
| 2025 | 4 | 0 | 0.00 | 0 | 0.00 | 0.00 | - |
| 2024 | 5 | 0 | 0.00 | 0 | 0.00 | 0.00 | - |
| 2023 | 9 | 0 | 0.00 | 0 | 0.00 | 0.00 | - |
| 2022 | 1 | 0 | 0.00 | 0 | 0.00 | 0.00 | - |
| 2021 | 6 | 0 | 0.00 | 0 | 0.00 | 0.00 | 1.55 |
| 2020 | 6 | 6 | 3.61 | 6 | 3.61 | 0.00 | 1.00 |
| 2019 | 14 | 25 | 18.67 | 25 | 18.67 | 0.00 | 0.50 |
| 2018 | 7 | 8 | 23.49 | 8 | 23.49 | 0.00 | 0.45 |
| 2017 | 7 | 8 | 28.31 | 8 | 28.31 | 0.00 | 0.58 |
| 2016 | 4 | 13 | 36.14 | 13 | 36.14 | 0.00 | 0.65 |
| 2015 | 8 | 8 | 40.96 | 8 | 40.96 | 0.00 | 0.65 |
| 2014 | 9 | 42 | 66.27 | 42 | 66.27 | 0.00 | 0.26 |
| 2013 | 11 | 17 | 76.51 | 17 | 76.51 | 0.00 | 0.00 |
| 2012 | 12 | 8 | 81.33 | 8 | 81.33 | 0.00 | 0.11 |
| 2011 | 11 | 3 | 83.13 | 3 | 83.13 | 0.00 | 0.00 |
| 2010 | 16 | 13 | 90.96 | 13 | 90.96 | 0.00 | 0.00 |
| 2007 | 3 | 5 | 93.98 | 5 | 93.98 | 0.00 | 0.04 |
| 2006 | 10 | 8 | 98.80 | 8 | 98.80 | 0.00 | 0.00 |
| 2005 | 13 | 1 | 99.40 | 1 | 99.40 | 0.00 | - |
| 2003 | 12 | 1 | 100.00 | 1 | 100.00 | 0.00 | - |